A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
Pfizer
Pfizer
Hoffmann-La Roche
University Health Network, Toronto
Adela, Inc
University Health Network, Toronto
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Incyte Corporation
University of Exeter
Rigshospitalet, Denmark
Tempus AI
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
Assistance Publique Hopitaux De Marseille
Checkpoint Therapeutics, Inc.
University Health Network, Toronto
Massachusetts General Hospital
Cyteir Therapeutics, Inc.
Taproot Health
University of Exeter
Cedars-Sinai Medical Center
Presage Biosciences
Celldex Therapeutics
CytomX Therapeutics
Fate Therapeutics
Hoffmann-La Roche
Eastern Cooperative Oncology Group
Seagen Inc.
Fate Therapeutics
Presage Biosciences
Incyte Corporation
Hospices Civils de Lyon
Institut Bergonié
Case Comprehensive Cancer Center
Tocagen Inc.
University of Wisconsin, Madison
University of California, San Diego
Stanford University
Amgen
Lytix Biopharma AS
sigma-tau i.f.r. S.p.A.
Memorial Sloan Kettering Cancer Center
Stanford University
Wuxi No. 4 People's Hospital
Stanford University
Valerio Therapeutics
Washington University School of Medicine
University of Chicago
Altor BioScience